The Germany Federal Ministry of Health's Paul-Ehrlich-Institut (PEI) has approved Emergent BioSolutions' (EBS -1.4%) large-scale Lansing, MI-based manufacturing site, Building 55, that will make its anthrax vaccine BioThrax. The approval allows product made there to be marketed in Germany, the only anthrax vaccine so licensed.